logo
Select company
Select metric
39.82%Gross Profits to Assets
VS
Market
81
Sector
80
Industry
87
History
96
$ 0.78Close
$ 0.53 - $ 4.4 52-Week Range
Ticker Information

Ticker

STRO

Company Name

SUTRO BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SUTRO BIOPHARMA INC - Gross Profits to Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STRO - GPA Historical data
DateTotal AssetsGross ProfitGross Profits to Assets
6/30/2025$ 262.36M$ 104.47M39.82%
3/31/2025$ 321.43M$ 66.43M20.67%
12/31/2024$ 387.21M$ 62.04M16.02%
9/30/2024$ 451.83M$ 160.96M35.62%
6/30/2024$ 489.04M$ 169.36M34.63%
3/31/2024$ 403.4M$ 154.06M38.19%
12/31/2023$ 470.74M$ 153.73M32.66%
9/30/2023$ 431.73M$ 48.64M11.27%
6/30/2023$ 464.9M$ 56.87M12.23%
3/31/2023$ 358.02M$ 74.55M20.82%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) GPA stands at 14.89%.
  • Over the past 5 years, SUTRO BIOPHARMA INC's average GPA has been 21.01%.
  • The median GPA for SUTRO BIOPHARMA INC during this period was 17.45%
  • SUTRO BIOPHARMA INC reached its highest GPA over the past 5 years at 39.82%.
  • The lowest GPA recorded by SUTRO BIOPHARMA INC in the same timeframe 10.84%

SUTRO BIOPHARMA INC's GPA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GPA Benchmarks
CompanyGPA
IPSC : CENTURY THERAPEUTICS INC 40.09%IGMS : IGM BIOSCIENCES INC 135.57%FBIO : FORTRESS BIOTECH INC 26.3%DOMH : DOMINARI HOLDINGS INC 48.3%MGX : METAGENOMI INC 12.4%ASRT : ASSERTIO HOLDINGS INC 29.03%LUNG : PULMONX CORP 44.95%KPTI : KARYOPHARM THERAPEUTICS INC 126.13%ICCC : IMMUCELL CORP 22.66%ATRA : ATARA BIOTHERAPEUTICS INC 415.36%

Definition of Gross Profits to Assets

[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].
GP / Assets
(=) GPA
GPA for SUTRO BIOPHARMA INC is calculated as follows: GP [ $ 45.75M ] / Assets [ $ 307.24M ]
(=) GPA [ 14.89% ]

STRO - Gross Profits to Assets, Last 5 years

10.84%

Minimum

Dec 31, 2020

39.82%

Maximum

Jun 30, 2025

21.01%

Average

17.45%

Median

GPA Benchmark Analysis

The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
filtered constituents4.13K
min-50.32%
max83.98%
average20.16%
median15.35%
std19.95%